Allied Market Research
Loading...
0
New
New
2021
Lycopene Market

Lycopene Market by Form, (Powder and Others), Nature (Natural and Synthetic), and Application (Food and Beverage, Nutraceuticals and Pharmaceuticals, and Cosmetics and Personal Care): Global Opportunity Analysis and Industry Forecast, 2021–2030

A06684
Pages: 255
Aug 2021 | 1943 Views
   
Author(s) : Himanshu Vig , Roshan Deshmukh
Tables: 137
Charts: 66
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Lycopene Market

Request Now !

The global lycopene market size was valued at $107.2 million in 2020, and is projected reach $187.3 million by 2030, registering a CAGR of 5.2% from 2021 to 2030. The powder segment led in terms of lycopene market share in 2020 and is expected to retain its dominance throughout the forecast period.

Lycopene is type of carotenoid which is most commonly found and extracted naturally from tomatoes. It has several medicinal properties, which has increased its demand in the nutraceutical market. Lycopene has a very high content of antioxidants, which helps fight free radicals in the body. Free radicals cause cell damage in the body, and consumption of lycopene helps in the reduction of these free radicals. Lycopene is also associated with the reduction in heart related diseases, and also, claims to reduce the risk of diabetes and certain types of cancers, such as lung, bone, and prostate cancers. Another advantage of lycopene is that it helps in maintaining cardio-vascular health. The most common source of lycopene in the body is consumption of fruits and vegetables containing lycopene. However, increase in consumption of fast food and adoption of unhealthy lifestyles have promoted the consumption of lycopene in the form of nutraceutical supplements. With growing studies across the world regarding health benefits of lycopene, the demand for the same is expected to rise in the nutraceutical industry.

Lycopene-Market

Get more information on this report : Request Sample Pages

With the growing population in the world, the global demand for animal feed is expected to amplify, owing to surge in consumption of meat products. According to the Food and Agriculture Organization (FAO), supplementation of livestock and poultry feed with natural fruit and plant material and extracts containing bioactive components has shown positive results. These additives are able to improve feed efficiency, antioxidant status, nutrient digestion, animal health, and growth performance. The major concern of the livestock industry is the epidemiological diseases, mainly confined to the immune systems, and digestion. Lycopene improve antioxidant capacity and immune function, and regulate lipid metabolism in chicken. Furthermore, diet supplemented with lycopene decreased the cholesterol content in meat of broilers. Owing to anti-oxidative benefits of lycopene, its demand is expected to witness a surge in the animal feed market.

Segment review

The global lycopene market is segmented on the basis of form, nature, application, and region. Based on form, the global lycopene market is bifurcated into powder and others. By nature, the market is segmented into natural and synthetic. Based on application, the global market is classified into food and beverage, nutraceuticals and pharmaceuticals, and cosmetics and personal care. By region, the global lycopene market is also studied across North America, Europe, Asia-Pacific, and LAMEA.

Lycopene Market
By Type

Your browser does not support the canvas element.

Powder segment would exhibit the highest CAGR of 5.5% during 2021-2030.

Get more information on this report : Request Sample Pages

By form, the lycopene market is segmented into powder and others Powder segment leads in terms of market share due to its high versatility in a myriad of applications and is expected to experience growth with highest CAGR during the forecast period.

Lycopene Market
By Form

Your browser does not support the canvas element.

Natural segment would exhibit the highest CAGR of 5.9% during 2021-2030.

Get more information on this report : Request Sample Pages

By nature, the lycopene market is categorized into natural lycopene and synthetic lycopene. Natural lycopene has become increasingly popular in the last few years. This is attributed to the fact that natural lycopene has witnessed increase in demand in various applications. Moreover, rise in consumer awareness about the side effects associated with synthetic counterparts has shifted their preference toward natural lycopene, which is regarded as safe for consumption.

By application, lycopene can be segmented into food and beverage, nutraceuticals and pharmaceuticals, & cosmetics and personal care. Lycopene is used in food mainly as a coloring agent to impart color to drinks, confectionaries and food items. Food and beverage segment leads in terms of market share however, nutraceutical and pharmaceutical segment is expected to grow with highest CAGR during the forecast period.

Lycopene Market
By Application

Your browser does not support the canvas element.

Nutraceuticals and pharmaceuticals segment would exhibit the highest CAGR of 5.9% during 2021-2030.

Get more information on this report : Request Sample Pages

The report focuses on the lycopene market growth prospects, restraints, and opportunities of the global lycopene market. The study provides Porter’s five forces analysis to understand the impact of various factors such as competitive intensity of competitors, bargaining power of suppliers, threat of substitutes, threat of new entrants, and bargaining power of buyers of the lycopene market.

Lycopene Market
By Region

2030
Europe 
North America
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 6.5% during 2021-2030.

Get more information on this report : Request Sample Pages

Some of the major players profiled for in the lycopene market analysis include Allied Biotech Corporation, Archer-Daniels-Midland Company, AromataGroup SRL, BASF SE, Divis Laboratories Ltd., Doehler Group SE, ExcelVite, Givaudan International SA, Kalsec Inc., and Koninklijke DSM N.V. Other prominent players analyzed in the report are Chr Hasen A/S, DDW The Color House, International Flavors & Fragrances Inc., Sensient Technologies Corporation, Cyanotech Corporation, and Kemin Industries, Inc.

COVID-19 Impact Analysis

  • Lycopene industry was slightly negatively impacted by the pandemic owing to disruption in supply chains.
  • The COVID-19 pandemic created new growth avenues for the supplement market. As a result, usage of lycopene in nutraceutical industry is projected to gain high traction in coming years. 
  • However, with changing consumer behavior demand for natural, clean label and premium quality products is anticipated to increase.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an extensive analysis of the current and emerging lycopene market trends and opportunities.
  • The report provides detailed qualitative and quantitative analysis of the current trends and future estimations that help evaluate the prevailing lycopene market opportunities in the market.
  • The lycopene market forecast is offered along with information related to key drivers, restraints, and opportunities.
  • The market analysis is conducted by following key product positioning and monitoring the top competitors within the market framework.
  • The report provides extensive qualitative insights on the potential and niche segments or regions exhibiting favorable growth.

Lycopene Market Segments

By Form

  • Powder
  • Others

By Nature

  • Natural
  • Synthetic

By Application

  • Food and Beverage
  • Nutraceuticals and pharmaceuticals
  • Cosmetics and Personal Care

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description 
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings

2.1.1.Top impacting factors
2.1.2.Top investment pockets

2.2.CXO perspective
2.3.View of Engaged Stakeholders

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Porter's five forces analysis

3.2.1.Bargaining power of suppliers
3.2.2.Bargaining power of buyers
3.2.3.Threat of substitution
3.2.4.Threat of new entrants
3.2.5.Intensity of competitive rivalry

3.3.Parent market overview
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Use of lycopene as a natural coloring agent in food and beverages to drive the market growth
3.4.1.2.Various health benefits of lycopene to benefit the nutraceutical industry
3.4.1.3.Skin repairing and skin improving qualities of lycopene to increase its adoption in cosmetic industry

3.4.2.Restraints

3.4.2.1.Availability of several other sources for red food coloring to impede market growth
3.4.2.2.Low stability of lycopene to challenge market expansion

3.4.3.Opportunities

3.4.3.1.Increase in consumer demand for clean label products can help provide impetus to the market
3.4.3.2.Newer demand from the animal feed industry can help create new growth avenues

3.5.Industry life cycle assessment, by region
3.6.Geographical concentration analysis of lycopene producers

CHAPTER 4:GLOBAL LYCOPENE MARKET, BY FORM

4.1.Overview

4.1.1.Market size and forecast, by Form

4.2.Powder

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Others

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

CHAPTER 5:GLOBAL LYCOPENE MARKET, BY NATURE

5.1.Overview

5.1.1.Market size and forecast, by Nature

5.2.Natural

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Synthetic

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

CHAPTER 6:GLOBAL LYCOPENE MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast, by Application

6.2.Food and Beverage

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Nutraceuticals and Pharmaceuticals

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

6.4.Cosmetics and Personal Care

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country

CHAPTER 7:LYCOPENE MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast, by region

7.2.North America

7.2.1.Overview
7.2.2.Key market trends, growth factors, and opportunities
7.2.3.Market size and forecast, by Form
7.2.4.Market size and forecast, by Nature
7.2.5.Market size and forecast, by Application
7.2.6.Market analysis, by Country

7.2.6.1.U.S.

7.2.6.1.1.Market size and forecast, by Form
7.2.6.1.2.Market size and forecast, by Nature
7.2.6.1.3.Market size and forecast, by Application

7.2.6.2.Canada

7.2.6.2.1.Market size and forecast, by Form
7.2.6.2.2.Market size and forecast, by Nature
7.2.6.2.3.Market size and forecast, by Application

7.2.6.3.Mexico

7.2.6.3.1.Market size and forecast, by Form
7.2.6.3.2.Market size and forecast, by Nature
7.2.6.3.3.Market size and forecast, by Application

7.3.Europe

7.3.1.Overview
7.3.2.Key market trends, growth factors, and opportunities
7.3.3.Market size and forecast, by Form
7.3.4.Market size and forecast, by Nature
7.3.5.Market size and forecast, by Application
7.3.6.Market analysis, by Country

7.3.6.1.UK

7.3.6.1.1.Market size and forecast, by Form
7.3.6.1.2.Market size and forecast, by Nature
7.3.6.1.3.Market size and forecast, by Application

7.3.6.2.Germany

7.3.6.2.1.Market size and forecast, by Form
7.3.6.2.2.Market size and forecast, by Nature
7.3.6.2.3.Market size and forecast, by Application

7.3.6.3.France

7.3.6.3.1.Market size and forecast, by Form
7.3.6.3.2.Market size and forecast, by Nature
7.3.6.3.3.Market size and forecast, by Application

7.3.6.4.Italy

7.3.6.4.1.Market size and forecast, by Form
7.3.6.4.2.Market size and forecast, by Nature
7.3.6.4.3.Market size and forecast, by Application

7.3.6.5.Spain

7.3.6.5.1.Market size and forecast, by Form
7.3.6.5.2.Market size and forecast, by Nature
7.3.6.5.3.Market size and forecast, by Application

7.3.6.6.Rest of Europe

7.3.6.6.1.Market size and forecast, by Form
7.3.6.6.2.Market size and forecast, by Nature
7.3.6.6.3.Market size and forecast, by Application

7.4.Asia-Pacific

7.4.1.Overview
7.4.2.Key market trends, growth factors, and opportunities
7.4.3.Market size and forecast, by Form
7.4.4.Market size and forecast, by Nature
7.4.5.Market size and forecast, by Application
7.4.6.Market analysis, by country

7.4.6.1.China

7.4.6.1.1.Market size and forecast, by Form
7.4.6.1.2.Market size and forecast, by Nature
7.4.6.1.3.Market size and forecast, by Application

7.4.6.2.Japan

7.4.6.2.1.Market size and forecast, by Form
7.4.6.2.2.Market size and forecast, by Nature
7.4.6.2.3.Market size and forecast, by Application

7.4.6.3.India

7.4.6.3.1.Market size and forecast, by Form
7.4.6.3.2.Market size and forecast, by Nature
7.4.6.3.3.Market size and forecast, by Application

7.4.6.4.ASEAN

7.4.6.4.1.Market size and forecast, by Form
7.4.6.4.2.Market size and forecast, by Nature
7.4.6.4.3.Market size and forecast, by Application

7.4.6.5.Australia

7.4.6.5.1.Market size and forecast, by Form
7.4.6.5.2.Market size and forecast, by Nature
7.4.6.5.3.Market size and forecast, by Application

7.4.6.6.South Korea

7.4.6.6.1.Market size and forecast, by Form
7.4.6.6.2.Market size and forecast, by Nature
7.4.6.6.3.Market size and forecast, by Application

7.4.6.7.Rest of Asia-Pacific

7.4.6.7.1.Market size and forecast, by Form
7.4.6.7.2.Market size and forecast, by Nature
7.4.6.7.3.Market size and forecast, by Application

7.5.LAMEA

7.5.1.Overview
7.5.2.Key market trends, growth factors, and opportunities
7.5.3.Market size and forecast, by Form
7.5.4.Market size and forecast, by Nature
7.5.5.Market size and forecast, by Application
7.5.6.Market analysis, by country

7.5.6.1.Brazil

7.5.6.1.1.Market size and forecast, by Form
7.5.6.1.2.Market size and forecast, by Nature
7.5.6.1.3.Market size and forecast, by Application

7.5.6.2.Argentina

7.5.6.2.1.Market size and forecast, by Form
7.5.6.2.2.Market size and forecast, by Nature
7.5.6.2.3.Market size and forecast, by Application

7.5.6.3.Saudi Arabia

7.5.6.3.1.Market size and forecast, by Form
7.5.6.3.2.Market size and forecast, by Nature
7.5.6.3.3.Market size and forecast, by Application

7.5.6.4.South Africa

7.5.6.4.1.Market size and forecast, by Form
7.5.6.4.2.Market size and forecast, by Nature
7.5.6.4.3.Market size and forecast, by Application

7.5.6.5.Rest of LAMEA

7.5.6.5.1.Market size and forecast, by Form
7.5.6.5.2.Market size and forecast, by Nature
7.5.6.5.3.Market size and forecast, by Application

CHAPTER 8:COMPETITION LANDSCAPE

8.1.Overview
8.2.Competitive dashboard
8.3.Competitive heat map
8.4.Product mapping
8.5.Top winning strategies
8.6.Key developments

8.6.1.Acquisition
8.6.2.Business Expansion
8.6.3.Product Launch
8.6.4.Partnership
8.6.5.Agreement
8.6.6.Collaboration
8.6.7.Joint venture
8.6.8.Merger

8.7.Top Player Positioning

CHAPTER 9:COMPANY PROFILE

9.1.ALLIED BIOTECH CORPORATION

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio

9.2.ARCHER DANIELS MIDLAND COMPANY

9.2.1.Company overview
9.2.2.Key executive
9.2.3.Company snapshot
9.2.4.Operating business segments
9.2.5.Product portfolio
9.2.6.R&D expenditure
9.2.7.Business performance
9.2.8.Key strategic moves and developments

9.3.AROMATAGROUP SRL

9.3.1.Company overview
9.3.2.Key Executives
9.3.3.Company snapshot
9.3.4.Operating business segments
9.3.5.Product portfolio
9.3.6.Key strategic moves and developments

9.4.BASF SE

9.4.1.Company overview
9.4.2.Key Executives
9.4.3.Company snapshot
9.4.4.Operating business segments
9.4.5.Product portfolio
9.4.6.Business performance
9.4.7.Key strategic moves and developments

9.5.DIVIS LABORATORIES LTD.

9.5.1.Company overview
9.5.2.Key Executives
9.5.3.Company snapshot
9.5.4.Operating business segments
9.5.5.Product portfolio
9.5.6.Business performance
9.5.7.Key strategic moves and developments

9.6.DOEHLER GROUP SE

9.6.1.Company overview
9.6.2.Key Executives
9.6.3.Company snapshot
9.6.4.Operating business segments
9.6.5.Product portfolio

9.7.EXCELVITE

9.7.1.Company overview
9.7.2.Key Executives
9.7.3.Company snapshot
9.7.4.Operating business segments
9.7.5.Product portfolio

9.8.Givaudan International SA (NATUREX S.A.)

9.8.1.Company overview
9.8.2.Key executive
9.8.3.Company snapshot
9.8.4.Operating business segments
9.8.5.Product portfolio
9.8.6.R&D expenditure
9.8.7.Business performance
9.8.8.Key strategic moves and developments

9.9.KALSEC INC.

9.9.1.Company overview
9.9.2.Key Executives
9.9.3.Company snapshot
9.9.4.Operating business segments
9.9.5.Product portfolio

9.10.KONINKLIJKE DSM N.V.

9.10.1.Company overview
9.10.2.Key executive
9.10.3.Company snapshot
9.10.4.Operating business segments
9.10.5.Product portfolio
9.10.6.R&D expenditure (Continued and discontinued operations)
9.10.7.Business performance (Continued and discontinued operations)

LIST OF TABLES

TABLE 01.GLOBAL LYCOPENE MARKET, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 02.GLOBAL POWDER LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 03.GLOBAL OTHERS LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 04.GLOBAL LYCOPENE MARKET, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 05.GLOBAL NATURAL LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 06.GLOBAL SYNTHETIC LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 07.GLOBAL LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 08.GLOBAL LYCOPENE MARKET FOR FOOD AND BEVERAGE INDUSTRY, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 09.GLOBAL LYCOPENE MARKET FOR NUTRACEUTICALS AND PHARMACEUTICALS INDUSTRY, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 10.GLOBAL LYCOPENE FOR COSMETICS AND PERSONAL CARE INDUSTRY, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 11.GLOBAL LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 12.NORTH AMERICA LYCOPENE MARKET VALUE, BY FORM 2020–2030 ($ THOUSAND)
TABLE 13.NORTH AMERICA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 14.NORTH AMERICA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 15.NORTH AMERICA LYCOPENE MARKET VALUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 16.U.S. LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 17.U.S. LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 18.U.S. LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 19.CANADA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 20.CANADA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 21.CANADA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 22.MEXICO LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 23.MEXICO LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 24.MEXICO LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 25.EUROPE LYCOPENE MARKET VALUE, BY FORM 2020–2030 ($ THOUSAND)
TABLE 26.EUROPE LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 27.EUROPE LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 28.EUROPE LYCOPENE MARKET VALUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 29.UK LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 30.UK LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 31.UK LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 32.GERMANY LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 33.GERMANY LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 34.GERMANY LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 35.FRANCE LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 36.FRANCE LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 37.FRANCE LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 38.ITALY LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 39.ITALY LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 40.ITALY LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 41.SPAIN LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 42.SPAIN LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 43.SPAIN LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 44.REST OF EUROPE LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 45.REST OF EUROPE LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 46.REST OF EUROPE LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 47.ASIA-PACIFIC LYCOPENE MARKET VALUE, BY FORM 2020–2030 ($ THOUSAND)
TABLE 48.ASIA-PACIFIC LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 49.ASIA-PACIFIC LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 50.ASIA-PACIFIC LYCOPENE MARKET VALUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 51.CHINA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 52.CHINA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 53.CHINA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 54.JAPAN LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 55.JAPAN LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 56.JAPAN LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 57.INDIA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 58.INDIA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 59.INDIA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 60.ASEAN LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 61.ASEAN LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 62.ASEAN LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 63.AUSTRALIA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 64.AUSTRALIA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 65.AUSTRALIA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 66.SOUTH KOREA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 67.SOUTH KOREA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 68.SOUTH KOREA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 69.REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 70.REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 71.REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 72.LAMEA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 73.LAMEA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 74.LAMEA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 75.LAMEA LYCOPENE MARKET VALUE, BY COUNTRY, 2020–2030 ($ MILLION)
TABLE 76.BRAZIL LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 77.BRAZIL LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 78.BRAZIL LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 79.ARGENTINA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 80.ARGENTINA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 81.ARGENTINA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 82.SAUDI ARABIA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 83.SAUDI ARABIA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 84.SAUDI ARABIA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 85.SOUTH AFRICA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 86.SOUTH AFRICA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 87.SOUTH AFRICA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 88.REST OF LAMEA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 89.REST OF LAMEA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 90.REST OF LAMEA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 91.ALLIED BIOTECH CORPORATION: COMPANY SNAPSHOT
TABLE 92.ALLIED BIOTECH CORPORATION: OPERATING SEGMENTS
TABLE 93.ALLIED BIOTECH CORPORATION: PRODUCT PORTFOLIO
TABLE 94.ARCHER DANIELS MIDLAND COMPANY: KEY EXECUTIVE
TABLE 95.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
TABLE 96.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS
TABLE 97.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO
TABLE 98.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 99.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
TABLE 100.AROMATAGROUP SRL: KEY EXECUTIVES
TABLE 101.AROMATAGROUP SRL: COMPANY SNAPSHOT
TABLE 102.AROMATAGROUP SRL: OPERATING SEGMENTS
TABLE 103.AROMATAGROUP SRL: PRODUCT PORTFOLIO
TABLE 104.BASF SE: KEY EXECUTIVES
TABLE 105.BASF SE: COMPANY SNAPSHOT
TABLE 106.BASF SE: OPERATING SEGMENTS
TABLE 107.BASF SE: PRODUCT PORTFOLIO
TABLE 108.BASF SE: NET SALES, 2018-2020 ($MILLION)
TABLE 109.DIVIS LABORATORIES LTD.: KEY EXECUTIVES
TABLE 110.DIVIS LABORATORIES LTD.: COMPANY SNAPSHOT
TABLE 111.DIVIS LABORATORIES LTD.: OPERATING SEGMENTS
TABLE 112.DIVIS LABORATORIES LTD.: PRODUCT PORTFOLIO
TABLE 113.DIVIS LABORATORIES LTD.: NET SALES, 2017–2019 ($MILLION)
TABLE 114.DOEHLER GROUP SE: KEY EXECUTIVES
TABLE 115.DOEHLER GROUP SE: COMPANY SNAPSHOT
TABLE 116.DOEHLER GROUP SE: OPERATING SEGMENTS
TABLE 117.DOEHLER GROUP SE: PRODUCT PORTFOLIO
TABLE 118.EXCELVITE: KEY EXECUTIVES
TABLE 119.EXCELVITE: COMPANY SNAPSHOT
TABLE 120.EXCELVITE: OPERATING SEGMENTS
TABLE 121.EXCELVITE: PRODUCT PORTFOLIO
TABLE 122.GIVAUDANINTERNATIONAL SA: KEY EXECUTIVE
TABLE 123.GIVAUDANINTERNATIONAL SA: COMPANY SNAPSHOT
TABLE 124.GIVAUDANINTERNATIONAL SA: OPERATING SEGMENTS
TABLE 125.GIVAUDANINTERNATIONAL SA: PRODUCT PORTFOLIO
TABLE 126.GIVAUDANINTERNATIONAL SA: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 127.GIVAUDANINTERNATIONAL SA: NET SALES, 2018-2020 ($MILLION)
TABLE 128.KALSEC INC: KEY EXECUTIVES
TABLE 129.KALSEC INC: COMPANY SNAPSHOT
TABLE 130.KALSEC INC: OPERATING SEGMENTS
TABLE 131.KALSEC INC: PRODUCT PORTFOLIO
TABLE 132.KONINKLIJKE DSM N.V.: KEY EXECUTIVE
TABLE 133.KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
TABLE 134.KONINKLIJKE DSM N.V.: OPERATING SEGMENTS
TABLE 135.KONINKLIJKE DSM N.V.: PRODUCT PORTFOLIO
TABLE 136.KONINKLIJKE DSM N.V.: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 137.KONINKLIJKE DSM N.V.: NET SALES, 2018-2020 ($MILLION)

LIST OF FIGURES

FIGURE 01.LYCOPENE MARKET OVERVIEW
FIGURE 02.KEY MARKET SEGMENTS
FIGURE 03.EXECUTIVE SUMMARY
FIGURE 04.TOP IMPACTING FACTORS
FIGURE 05.TOP INVESTMENT POCKETS
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTION
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 11.GLOBAL LYCOPENE MARKET, BY FORM, 2020 (%)
FIGURE 12.COMPARATIVE VALUE SHARE ANALYSIS OF POWDER LYCOPENE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 13.COMPARATIVE VALUE SHARE ANALYSIS OF OTHERS LYCOPENE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 14.GLOBAL LYCOPENE MARKET, BY NATURE, 2020 (%)
FIGURE 15.COMPARATIVE VALUE SHARE ANALYSIS OF GLOBAL NATURAL LYCOPENE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16.COMPARATIVE VALUE SHARE ANALYSIS OFSYNTHETIC LYCOPENE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 17.GLOBAL LYCOPENE MARKET, BY APPLICATION, 2020 (%)
FIGURE 18.COMPARATIVE VALUE SHARE ANALYSIS OF LYCOPENE FOR FOOD AND BEVERAGEINDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 19.COMPARATIVE VALUE SHARE ANALYSIS OF LYCOPENE SALES FOR NUTRACEUTICALS AND PHARMACEUTICALS INDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 20.COMPARATIVE VALUE SHARE ANALYSIS OF SALES OF LYCOPENE FOR COSMETICS AND PERSONAL CARE INDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 21.GLOBAL LYCOPENE MARKET, BY REGION 2020 (%)
FIGURE 22.U.S. LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 23.CANADA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 24.MEXICO LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 25.UK LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 26.GERMANY LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 27.FRANCE LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 28.ITALY LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 29.SPAIN LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 30.REST OF EUROPE LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 31.CHINA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 32.JAPAN LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 33.INDIA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 34.ASEAN LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 35.AUSTRALIA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 36.SOUTH KOREA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 37.REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 38.BRAZIL LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 39.ARGENTINA LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 40.SAUDI ARABIA LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 41.SOUTH AFRICA LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 42.REST OF LAMEA LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 43.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 45.PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 46.TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 47.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%)
FIGURE 48.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021*
FIGURE 49.PLAYER POSITIONING OF TOP 10 KEY PLAYERS
FIGURE 50.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 51.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
FIGURE 52.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 53.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 54.BASF SE: NET SALES, 2018-2020 ($MILLION)
FIGURE 55.BASF SE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 56.BASF SE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 57.DIVIS LABORATORIES LTD.: NET SALES, 2017–2019 ($MILLION)
FIGURE 58.DIVIS LABORATORIES LTD.: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 59.GIVAUDANINTERNATIONAL SA: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 60.GIVAUDANINTERNATIONAL SA: NET SALES, 2018-2020 ($MILLION)
FIGURE 61.GIVAUDANINTERNATIONAL SA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 62.GIVAUDANINTERNATIONAL SA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 63.KONINKLIJKE DSM N.V.: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 64.KONINKLIJKE DSM N.V.: NET SALES, 2018-2020 ($MILLION)
FIGURE 65.KONINKLIJKE DSM N.V.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 66.KONINKLIJKE DSM N.V.: REVENUE SHARE BY REGION, 2020 (%)

 
 

Recent years have seen an increase in demand for food ingredients that are healthy and natural. Primary reason for this demand increase is the rising awareness of the several health benefits that are inherent with the consumption of food and beverages that have naturally sourced or nature identical ingredients. It has led to an increase in the use of lycopene as an ingredient in many types of food and beverages.

Lycopene is a natural carotenoid most commonly extracted from tomatoes. Synthetic lycopene is also commonly used to impart a light to dark red color to the food that is being produced. However, the shift in consumer perception that favors natural ingredients has led to a wider adoption of natural lycopene by the engaged stakeholders. The various health benefits associated with lycopene have also led to usage of the same in nutraceutical and cosmetics industries, as there is also a demand for natural supplements and personal care products by the consumers.

There is increased awareness in consumers about negative impact on health due to synthetic ingredients as a result this has led to the introduction of organic lycopene in the market, which is sourced form organically grown tomatoes. Innovations and advancement of extraction technology are expected to provide lucrative opportunities for the engaged stakeholders in the lycopene market.    

 

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The lycopene market is expected to reach $187 million by 2030

A. The lycopene market is poised to grow with CAGR of 5.2% from 2021 to 2030.

A. Kindly raise an inquiry through the chat box and our business executive will get in touch with you with the details on the purchase options.

A. 2020 is the base year used for calculation in the lycopene market report.

A. Some of the major players operating in the lycopene market analysis include Allied Biotech Corporation, Archer-Daniels-Midland Company, AromataGroup SRL, BASF SE, Divis Laboratories Ltd., Doehler Group SE, ExcelVite, Givaudan International SA, Kalsec Inc., and Koninklijke DSM N.V.

A. The lycopene market is segmented on the basis of form, nature, application and region.

A. The Asia-Pacific region is likely to provide lucrative opportunities for the engaged stakeholders.

A. The lycopene market is going to see increased demand in the post Covid-19 scenario.

Allied Market Research Allied Market Research Allied Market Research
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Lycopene Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,713
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,126
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,169
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,930
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,665
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers